Electromed, Inc. (ELMD)
Electromed, Inc. (ELMD) is a medical device company focused on developing and commercializing airway clearance solutions. Its flagship product, the AIRWAY RESCUE System, utilizes SmartVest technology to aid patients with conditions such as bronchiectasis, COPD, and cystic fibrosis by helping to loosen and remove mucus from the lungs. The company emphasizes minimally invasive therapies aimed at improving respiratory health and reducing the need for more aggressive treatments.
Company News
Upgrades Northcoast Research upgraded the previous rating for Ecolab Inc (NYSE:ECL) from Neutral to Buy. Ecolab earned $1.10 in the second quarter, compared to $1.22 in the year-ago quarter. The stock has a 52-week-high of $237.38 and a 52-week-low of $143.82. At the end of the last trading period, Ecolab closed at $161.64. According to Northc...
Electromed, Inc. (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.